Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
227,306,614
-
Number of holders
-
109
-
Total 13F shares, excl. options
-
53,088,201
-
Shares change
-
-1,156,924
-
Total reported value, excl. options
-
$431,075,177
-
Value change
-
-$10,198,257
-
Put/Call ratio
-
822%
-
Number of buys
-
44
-
Number of sells
-
-58
-
Price
-
$8.12
Significant Holders of Gossamer Bio, Inc. - Common Stock (GOSS) as of Q2 2021
139 filings reported holding GOSS - Gossamer Bio, Inc. - Common Stock as of Q2 2021.
Gossamer Bio, Inc. - Common Stock (GOSS) has 109 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 53,088,201 shares
of 227,306,614 outstanding shares and own 23.4% of the company stock.
Largest 10 shareholders include HHLR ADVISORS, LTD. (7,420,974 shares), VANGUARD GROUP INC (5,433,078 shares), BlackRock Inc. (5,415,805 shares), STATE STREET CORP (3,327,716 shares), Omega Fund Management, LLC (3,320,608 shares), FEDERATED HERMES, INC. (2,962,200 shares), BOXER CAPITAL, LLC (2,562,358 shares), Artal Group S.A. (2,358,968 shares), Palo Alto Investors LP (1,772,950 shares), and Octagon Capital Advisors LP (1,413,138 shares).
This table shows the top 109 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.